Ocular Hypotensive Efficacy and Safety of the Rho Kinase Inhibitor AR-12286 in Patients With Elevated Intraocular Pressure

被引：0

作者：

Williams, R. D. ^{[1
]}

Novack, G. D. ^{[2
]}

van Haarlem, T. ^{[3
]}

Kopczynski, C. ^{[4
]}

机构：

[1] Clin Res Ctr, Louisville, KY USA

[2] PharmaLog Dev Inc, San Rafael, CA USA

[3] Aerie Pharmaceut Inc, Bridgewater, NJ USA

[4] Aerie Pharmaceut Inc, Res Triangle Pk, NC USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期

关键词：

intraocular pressure; trabecular meshwork; clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

1633

引用

页数：2

共 42 条

[21] Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma
Koichi Ono
Fumika Sakemi
Tatsuya Marumoto
International Ophthalmology, 2021, 41 : 605 - 611
[22] Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma
Ono, Koichi
Sakemi, Fumika
Marumoto, Tatsuya
INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (02) : 605 - 611
[23] A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure
Yüksel, NE
Karabas, L
Altintas, Ö
Yildirim, Y
Çaglar, Y
OPHTHALMOLOGICA, 2002, 216 (01) : 45 - 49
[24] Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
Inazaki, Hiroshi
Kobayashi, Satoshi
Anzai, Yoko
Satoh, Hisayoshi
Sato, Shimpei
Inoue, Maiko
Yamane, Shin
Kadonosono, Kazuaki
JOURNAL OF GLAUCOMA, 2017, 26 (02) : 96 - 100
[25] Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
Wang, Kaidi
Xu, Li
Yuan, Zhilan
Yao, Ke
Zhao, Junmei
Xu, Liang
Fang, Aiwu
Zhang, Mingzhi
Wu, Lingling
Ji, Jian
Hou, Jiamin
Liu, Qing
Sun, Xinghuai
BMC OPHTHALMOLOGY, 2014, 14
[26] Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
Kaidi Wang
Li Xu
Zhilan Yuan
Ke Yao
Junmei Zhao
Liang Xu
Aiwu Fang
Mingzhi Zhang
Lingling Wu
Jian Ji
Jiamin Hou
Qing Liu
Xinghuai Sun
BMC Ophthalmology, 14
[27] Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Sato, Shino
Hirooka, Kazuyuki
Nitta, Eri
Ukegawa, Kaori
Tsujikawa, Akitaka
ADVANCES IN THERAPY, 2016, 33 (09) : 1628 - 1634
[28] Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Shino Sato
Kazuyuki Hirooka
Eri Nitta
Kaori Ukegawa
Akitaka Tsujikawa
Advances in Therapy, 2016, 33 : 1628 - 1634
[29] AMA0076, a Novel, Locally Acting Rho Kinase Inhibitor, Potently Lowers Intraocular Pressure in New Zealand White Rabbits with Minimal Hyperemia
de Velde, Sarah Van
Van Bergen, Tine
Sijnave, Davine
Hollanders, Karolien
Castermans, Karolien
Defert, Olivier
Leysen, Dirk
Vandewalle, Evelien
Moons, Lieve
Stalmans, Ingeborg
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (02) : 1006 - 1016
[30] One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Tsukahara, Shun
Enomoto, Nobuko
Ishida, Kyoko
Anraku, Ayako
Tomita, Goji
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (07) : 512 - 521

← 1 2 3 4 5 →